Quick Answer
Senti Biosciences Holdings, Inc. reported Shares Outstanding of 30.88 million shares for fiscal year 2025.
Senti Biosciences Holdings, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 30.88M | +539.5% |
| 2024 | 4.83M | +5.7% |
| 2023 | 4.57M | -89.6% |
| 2022 | 44.06M | +1.6% |
| 2022 | 43.37M | +1359.0% |
| 2021 | 2.97M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 26.29M | +473.2% | +0.5% |
| June 30, 2025 | 26.16M | +472.1% | +0.6% |
| March 31, 2025 | 26.00M | -43.1% | +438.5% |
| December 31, 2024 | 4.83M | +5.7% | +5.3% |
| September 30, 2024 | 4.59M | -89.7% | +0.3% |
| June 30, 2024 | 4.57M | -89.7% | -90.0% |
| March 31, 2024 | 45.71M | +3.7% | +900.3% |
| December 31, 2023 | 4.57M | -89.6% | -89.7% |
- Senti Biosciences Holdings, Inc. showed an increase of +539.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, Senti Biosciences Holdings, Inc.’s shares outstanding has grown by 938.9% (from 2.97 million shares to 30.88 million shares).
- The most recent figure is from Senti Biosciences Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: